Back to Journals » Therapeutics and Clinical Risk Management » Volume 12

The potential utilizations of hydrogen as a promising therapeutic strategy against ocular diseases

Authors Tao Y, Geng L, Xu W, Qin L, Peng G, Huang YF

Received 15 December 2015

Accepted for publication 2 March 2016

Published 19 May 2016 Volume 2016:12 Pages 799—806


Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Professor Deyun Wang

Ye Tao,1,* Lei Geng,2,* Wei-Wei Xu,1 Li-Min Qin,1 Guang-Hua Peng,1 Yi-Fei Huang1

1Department of Ophthalmology, 2Department of Orthopaedics, Chinese People’s Liberation Army General Hospital, Ophthalmology & Visual Science Key Lab of PLA, Beijing, People’s Republic of China

*These authors contributed equally to this work

Abstract: Hydrogen, one of the most well-known natural molecules, has been used in numerous medical applications owing to its ability to selectively neutralize cytotoxic reactive oxygen species and ameliorate hazardous inflammations. Hydrogen can exert protective effects on various reactive oxygen species-related diseases, including the transplantation-induced intestinal graft injury, chronic inflammation, ischemia–reperfusion injuries, and so on. Especially in the eye, hydrogen has been used to counteract multiple ocular pathologies in the ophthalmological models. Herein, the ophthalmological utilizations of hydrogen are systematically reviewed and the underlying mechanisms of hydrogen-induced beneficial effects are discussed. It is our hope that the protective effects of hydrogen, as evidenced by these pioneering studies, would enrich our pharmacological knowledge about this natural element and cast light into the discovery of a novel therapeutic strategy against ocular diseases.

Keywords: hydrogen, therapeutic strategy, ocular diseases

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]